October 14, 2025
Gram-negative Bacteremia Treatment Pathway
This treatment pathway is intended for patients with uncomplicated Gram-negative bacteremia with a known pathogen and pending microbiological susceptibility testing results.
Resource Organism: Bacteria
September 22, 2025
Diagnosis and Management of Clostridioides difficile Infection in Adult and Pediatric Patients
c. diff, c. difficile, fidaxomicin, bezlotoxumab, vancomycin, Clostridioides difficile, CDI, diarrhea, Clostridium difficile
July 11, 2025
UNC Medical Center Antibiogram
Antimicrobial susceptibility organisms submitted to the University of North Carolina Hospitals Microbiology Laboratory between 1/1/2024 and 12/31/2024. Antibiograms help guide the clinician and pharmacist in selecting the best empiric antimicrobial treatment in the event of pending microbiology culture and susceptibility results.
June 9, 2024
Best Practices for Treatment of Community-acquired Bacterial Pneumonia in Hospitalized Adults
community, acquired, CAP
February 9, 2024
Guidance for the Empiric Use of Restricted Beta-lactams with Activity Against Carbapenem-resistant Enterobacterales
CRE, OXA-48, KPC, ceftazidime-avibactam, meropenem-vaborbactam, carbapenem resistant, imipenem-relebactam, cefidericol, B-lactam
September 1, 2023
Antibiotic Locks for the Treatment of Prevention of Catheter-related Bloodstream Infections
vancomycin, gentamicin, line, salvage, CLABSI, hemodialysis line, blood, infection
July 25, 2023
Staphylococcus aureus Bacteremia Management
MRSA, MSSA, Staphylococcus, Staphylococcus aureus, S.aureus, Blood stream, s aureus
January 17, 2023
Vancomycin-resistant Enterococcus (VRE) Treatment
VRE, vancomycin resistant, enterococcus, e.faecalis, e.faecium, daptomycin, Enterococcus
March 30, 2022
Aminoglycoside Dosing & Monitoring: Neonatal & Pediatric Guideline
Aminoglycoside; Gram-negative; Gram-positive;
May 1, 2021
Laboratory Monitoring Guideline for Outpatient Parenteral and Oral Antimicrobial Therapy for Pediatrics and Adults
OPAT